Am I Nuts Being Out Of AstraZeneca plc, British American Tobacco plc And BP plc?

High dividends at AstraZeneca plc (LON: AZN), British American Tobacco plc (LON: BATS) and BP (LON: BP) really do attract but are they all worth investing in?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Am I nuts being out of AstraZeneca (LSE: AZN), British American Tobacco (LSE: BATS) and BP (LSE: BP) when they have such tempting dividend yields?

At a share price of 4,017p, City analysts forecast that AstraZeneca will yield a dividend of 4.8% for 2016, at 4,115p British American Tobacco’s forward yield is 4%, and at 341p BP’s is 8%.

Better than cash

Those potential returns are better than anything I can get saving cash, so investing in big firms on the stock market looks attractive.

Should you invest £1,000 in Hollywood Bowl Group Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Hollywood Bowl Group Plc made the list?

See the 6 stocks

The problem is that shares can go down as well as up and it’s natural to worry that shrinking capital values might erode any gains from dividend income in the years ahead. However, if I pick the right companies, it’s worth taking the risk. After all, shares can go up as well as down and capital gains from rising share prices could augment my gains from dividend income.

AstraZeneca and British American Tobacco both expect their forward earnings to cover their dividend payouts around 1.4 times during 2016. Both firms produce consumable goods that customers love to repeat-purchase. Tobacco products and medicines tend to be high on the purchase list of consumers that need them.

Such market dynamics keep the cash flowing and that shows in the consistency of the dividend records for these two companies. Over the last five years, AstraZeneca has produced a flat dividend and British American Tobacco has raised its annual payout by around 30%. On top of that, over the same five-year period AstraZeneca’s shares are up around 34% and British American Tobacco’s near 70%.

A different tale

The story is different at BP. Over five years the dividend has been patchy due to the after effects of the firm’s Gulf of Mexico oil spill and the share price is down around 28%. BP doesn’t produce cash-generating consumer goods like the other two. Instead, it produces a commodity that’s at the mercy of fluctuating market prices.

Right now, the oil price is down and BP expects its forward earnings to cover the dividend payout less than 0.5 times during 2016. The firm’s dividend looks vulnerable, and if I invest in BP now I need to take a view on where the price of oil might be going in the future.

Because of the cyclical nature of BP’s operation and the fact that earnings recently collapsed, the firm’s valuation looks odd. For 2016, the company’s forward price-to-earnings (P/E) ratio sits at 28, whereas AstraZeneca’s sits at 14.5 and British American Tobacco’s is 18.

I’m more nuts being out of AstraZeneca and British American Tobacco than I am being out of BP. An investment in BP looks speculative and seems to net out to betting on a rising oil price. Whereas, based on their business models, it seems reasonable to expect further steady operational progress from AstraZeneca and British American Tobacco. AstraZeneca’s patent-cliff-induced slide in earnings seems set to halt in the coming years as new drugs come through from the firm’s development pipeline to bolster earnings. British American Tobacco expects its earnings to rise by 9% during 2016 and a further 8% in 2017.

Should you buy Hollywood Bowl Group Plc now?

Don’t make any big decisions yet.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — has revealed 5 Shares for the Future of Energy.

And he believes they could bring spectacular returns over the next decade.

Since the war in Ukraine, nations everywhere are scrambling for energy independence, he says. Meanwhile, they’re hellbent on achieving net zero emissions. No guarantees, but history shows...

When such enormous changes hit a big industry, informed investors can potentially get rich.

So, with his new report, Mark’s aiming to put more investors in this enviable position.

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

We think earning passive income has never been easier

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

More on Investing Articles

Electric cars charging in station
Investing Articles

Looking at Tesla stock? Consider this Warren Buffett-held EV rival instead

Tesla stock is one of the most popular investments in the UK right now. However, Edward Sheldon sees more appeal…

Read more »

Investing Articles

Up 18% in the past week, I think this FTSE 100 share could keep soaring!

While the FTSE 100's up 5.6% in the past week, this blue-chip share's risen much more sharply. Can it move…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

2 top growth stocks to consider buying for the next phase of the AI revolution

The artificial intelligence (AI) revolution is advancing rapidly on the application side, setting up these two growth stocks for more…

Read more »

Growth Shares

Will the Lloyds share price be a winner or loser from the tariffs turmoil?

Jon Smith explains both sides of the argument when trying to figure out if the Lloyds share price will move…

Read more »

Investing For Beginners

Aston Martin: is there a real risk the FTSE company goes bust?

Jon Smith notes the struggles over the past few years of an iconic car brand, but explains why his head…

Read more »

Growth Shares

2 crackerjack growth shares to consider buying as the dust settles

Jon Smith talks through a couple of growth shares that he feels represent good value for investors right now as…

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

I’ve been investing in the stock market for 25 years. Here are 4 tips to navigate the current volatility

Investing during periods of extreme stock market volatility isn’t easy. Here, Edward Sheldon provides his top tips to get through…

Read more »

Investing Articles

£10,000 invested in Tesla shares a fortnight ago is now worth…

Despite extreme volatility, the value of a £10,000 investment in Tesla shares from a fortnight ago hasn’t changed much. That’s…

Read more »